Jonathan B. Siegel, Director at Jaguar Health, Inc. (JAGX), bought 268 shares at $1.19 ($319) on 2018-07-17, disclosed to the SEC on 2018-10-04.
Open-market purchase of $319 JAGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| JAGX | BUY | 2018-07-20 | $6K | — | Filing → |
| JAGX | BUY | 2018-07-18 | $13K | — | Filing → |